These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22961568)

  • 21. Adipose Tissue Transferrin and Insulin Resistance.
    McClain DA; Sharma NK; Jain S; Harrison A; Salaye LN; Comeau ME; Langefeld CD; Lorenzo FR; Das SK
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4197-4208. PubMed ID: 30099506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults.
    Krisai P; Leib S; Aeschbacher S; Kofler T; Assadian M; Maseli A; Todd J; Estis J; Risch M; Risch L; Conen D
    Eur J Intern Med; 2016 Jul; 32():31-7. PubMed ID: 27113814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum ferritin is inversely correlated with serum adiponectin level: population-based cross-sectional study.
    Ku BJ; Kim SY; Lee TY; Park KS
    Dis Markers; 2009; 27(6):303-10. PubMed ID: 20075513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender difference in type 2 diabetes and the role of body iron stores.
    Aregbesola A; Voutilainen S; Virtanen JK; Mursu J; Tuomainen TP
    Ann Clin Biochem; 2017 Jan; 54(1):113-120. PubMed ID: 27166309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors accounting for high ferritin levels in obesity.
    Lecube A; Hernández C; Pelegrí D; Simó R
    Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnosine supplementation reduces plasma soluble transferrin receptor in healthy overweight or obese individuals: a pilot randomised trial.
    Baye E; Ukropec J; de Courten MPJ; Kurdiova T; Krumpolec P; Fernández-Real JM; Aldini G; Ukropcova B; de Courten B
    Amino Acids; 2019 Jan; 51(1):73-81. PubMed ID: 30136029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin and iron induce insulin resistance of glucose transport in adipocytes.
    Green A; Basile R; Rumberger JM
    Metabolism; 2006 Aug; 55(8):1042-5. PubMed ID: 16839839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
    al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
    Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
    Mojiminiyi OA; Marouf R; Abdella NA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common presence of non-transferrin-bound iron among patients with type 2 diabetes.
    Lee DH; Liu DY; Jacobs DR; Shin HR; Song K; Lee IK; Kim B; Hider RC
    Diabetes Care; 2006 May; 29(5):1090-5. PubMed ID: 16644642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes.
    Lu HL; Wang HW; Wen Y; Zhang MX; Lin HH
    World J Gastroenterol; 2006 Mar; 12(11):1747-51. PubMed ID: 16586545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of iron markers with type 2 diabetes mellitus and metabolic syndrome: Results from the prospective SHIP study.
    Pitchika A; Schipf S; Nauck M; Dörr M; Lerch MM; Felix SB; Markus MRP; Völzke H; Ittermann T
    Diabetes Res Clin Pract; 2020 May; 163():108149. PubMed ID: 32304796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum ferritin and glucose homeostasis: change in the association by glycaemic state.
    Aregbesola A; Virtanen JK; Voutilainen S; Mursu J; Lagundoye A; Kauhanen J; Tuomainen TP
    Diabetes Metab Res Rev; 2015 Jul; 31(5):507-14. PubMed ID: 25470760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin, Insulin Sensitivity and Diabetic Retinopathy in Latinos With Type 2 Diabetes.
    Kuo JZ; Guo X; Klein R; Klein BE; Genter P; Roll K; Hai Y; Goodarzi MO; Rotter JI; Chen YD; Ipp E
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3348-55. PubMed ID: 26020763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Fumeron F; Péan F; Driss F; Balkau B; Tichet J; Marre M; Grandchamp B;
    Diabetes Care; 2006 Sep; 29(9):2090-4. PubMed ID: 16936158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in transferrin are related to changes in insulin resistance: the SLIM study.
    Roumen C; Feskens EJ; Jansen EH; Saris WH; Blaak EE
    Diabet Med; 2008 Dec; 25(12):1478-82. PubMed ID: 19046249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance.
    Medina-Urrutia A; Posadas-Romero C; Posadas-Sánchez R; Jorge-Galarza E; Villarreal-Molina T; González-Salazar Mdel C; Cardoso-Saldaña G; Vargas-Alarcón G; Torres-Tamayo M; Juárez-Rojas JG
    Cardiovasc Diabetol; 2015 Feb; 14():20. PubMed ID: 25849597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance.
    Almuraikhy S; Kafienah W; Bashah M; Diboun I; Jaganjac M; Al-Khelaifi F; Abdesselem H; Mazloum NA; Alsayrafi M; Mohamed-Ali V; Elrayess MA
    Diabetologia; 2016 Nov; 59(11):2406-2416. PubMed ID: 27342408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.